Trial Condition(s):

Hormone replacement therapy (HRT)

Angeliq low/low: MD PK

Bayer Identifier:

13300

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2008-004693-40

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

April2009

July2009

Phase

Could I receive a placebo?

Products

Low-Dose E2/DRSP (BAY86-4891)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Status

Locations	Status
Locations Bayer Schering Pharma AG Berlin, Germany, 13353	Status Completed		Contact Us: E-mail: [email protected] Phone: Not Available

Locations

Status

Locations

Bayer Schering Pharma AG

Berlin, Germany, 13353

Status

Completed

Contact Us:

E-mail: [email protected]

Phone: Not Available

Hormone replacement therapy (HRT)

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

Trial Purpose

Key Participation Requirements

sex

age

45 Years

75 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information